Abstract
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, with atherosclerosis accounting for most deaths. Inflammation is a key component in the pathogenesis of CVDs such as atherosclerosis, stroke, myocarditis, dilated cardiomyopathy, and heart failure. A number of recent clinical and animal model findings suggest that the pathogenesis of autoimmune and CVDs may be linked. Many potentially modifiable risk factors like diet, tobacco smoking, and infections have been associated with increased cardiovascular risk for both atherosclerosis and several autoimmune diseases including myocarditis, systemic lupus erythematosus, and rheumatoid arthritis. Although many autoimmune diseases are more prevalent in women, the risk for developing CVD remains elevated in men. Future studies should examine sex differences in CVD biomarkers following infection and/or toxicant exposure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdo AS, Kemp R, Barham J, Geraci SA (2010) Dilated cardiomyopathy and role of antithrombotic therapy. Am J Med Sci 339:557–560
Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL, Rose NR (2001) Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 159:193–203
Afanasyeva M, Georgakopoulos D, Fairweather D, Caturegli P, Kass DA, Rose NR (2004) A novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-γ knockout mice. Circulation 110:2910–2917
Aguero J, Navarro J, Medina MC, Almenar L, Chirivella M, Martinez-Dolz L, Moro JA, Sanchez-Lazaro I, Ortiz V, Raso R, Salvador A (2008) Clinical variables associated with the presence of inflammatory infiltrates in patients with dilated cardiomyopathy undergoing heart transplantation. Transplant Proc 40:3017–3019
Antoniak S, Boltzen U, Riad A, Kallwellis-Opara A, Rohde M, Dorner A, Tschope C, Noutsias M, Pauschinger M, Schultheiss H-P, Rauch U (2008) Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity. J Mol Cell Cardiol 45:118–126
Ashrafi R, Garg P, McKay E, Gosney J, Chuah S, Davis G (2011) Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review. Cardiol Res Pract 2011:578390 10.4061/2011/578390
Bae S, Ke Q, Koh YY, Lee W, Choi JH, Kang PM, Morgan JP (2010) Exacerbation of acute viral myocarditis by tobacco smoke is associated with increased viral load and cardiac apoptosis. Can J Physiol Pharmacol 88:568–575
Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, Zheng D, Gabrielson K, Iwakura Y, Rose NR, Cihakova D (2010) Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 106:1646–1655
Bartoloni E, Alunno A, Luccioli F, Moscatelli S, Biscontini D, Santoboni G, Gerli R (2010) Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link. Expert Rev Cardiovasc Ther 8:1309–1316
Beckman JA, Creager MA, Libby P (2002) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570–2581
Blauwet LA, Cooper LT (2010) Myocarditis. Prog Cardiovasc Dis 52:274–288
Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, Luscher TF, Eriksson U (2009) Myeloid differentiation factor-88/interleukin-1 signaling cotnrols cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ Res 105:912–920
Bonita R, Duncan J, Truelsen T, Jackson RT, Beaglehole R (1999) Passive smoking, as well as active smoking, increases the risk of acute stroke. Tob Control 8:156–160
Brevitti G, Giugliano G, Brevitti L, Hiatt WR (2010) Inflammation in peripheral artery disease. Circulation 122:1862–1875
Carter AM (2005) Inflammation, thrombosis and acute coronary syndromes. Diab Vasc Dis Res 2:113–121
Chahine LM, Khoriaty RN, Tomford WJ, Hussain MS (2011) The changing face of neurosyphilis. Int J Stroke 6:136–143
Chakraborty S, Zawieja S, Wang W, Zawieja DC, Mathuchamy M (2010) Lymphatic system: a vital link between metabolic syndrome and inflammation. Ann N Y Acad Sci 1207(suppl 1):E94–E102
Cihakova D, Rose NR (2008) Pathogenesis of myocarditis and dilated cardiomyopathy. Adv Immunol 99:95–114
Cooper LT Jr (2000) Giant cell myocarditis: diagnosis and treatment. Herz 25:291–298
Cooper LT Jr (2009) Myocarditis. N Engl J Med 360:1526–1538
Cooper SC, Miller FW (2007) Environmental influences on autoimmunity and autoimmune diseases. In: Luebke R, House R, Kimber I (eds) Immunotoxicology and immunopharmacology, 3rd edn. CRC Press, Boca Raton, pp 437–453
Cooper LT, Belohlavek M, Korinek J, Yoshifuku S, Sengupta PP, Burgstaler EA, Winters JL (2007) A pilot study to assess the use of protein A immunoadsorption for chronic dilated cardiomyopathy. J Clin Apher 22:210–214
Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW, for the Giant Cell Myocarditis Treatment Trial Investigators (2008) Usefulness of immunsuppression for giant cell myocarditis. Am J Cardiol 102:1535–1539
Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, Yano K, Tracy RP (2003) C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 107:2016–2020
Daniels MD, Hyland KV, Wang K, Engman DM (2008) Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity. Autoimmunity 41:490–499
Diedrich M, Tadic J, Mao L, Wacker MA, Nebrich G, Hetzer R, Regits-Zagrosek V, Klose J (2007) Heart protein expression related to age and sex in mice and humans. Int J Mol Med 20:865–874
Dixon WG, Watson KD, Lunt M, Hyrich KL, British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56:2905–2912
Doria A, Pauletto P (2004) The heart in systemic autoimmune diseases. Elsevier, Amsterdam
Doria A, Petri M (2004) Cardiac involvement in systemic lupus erythematosus. In: Doria A, Pauletto P (eds) The heart in systemic autoimmune diseases. Elsevier, Amsterdam, pp 145–161
Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M (2005) Cardiac involvement in systemic lupus erythematosus. Lupus 14:683–686
Drake C, Boutin H, Jones MS, Denes A, McColl BW, Selvaraiah JR, Hulme S, Georgiou RF, Hinz R, Gerhard A, Vail A, Prenant C, Julvan P, Marov R, Brown G, Smiqova A, Herholz K, Kassiou M, Corssman D, Francis S, Proctor SD, Russell JC, Hopkins SJ, Tyrrell PJ, Rothwell NJ, Allan SM (2010) Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun 25:1113–1122
Dube SR, Fairweather D, Pearson W, Felitti VJ, Anda RF, Croft JB (2009) Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med 71:243–250
Elkind MSV (2010) Inflammatory mechanisms of stroke. Stroke 41(suppl 1):S3–S8
Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:132–140
Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Cote R, Grover SA, Fortin PR, Clarke AE, Senecal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337
Esfandiarei M, McManus BM (2008) Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 3:127–155
Fairweather D, Cihakova D (2009) Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 33:222–230
Fairweather D, Rose NR (2007a) Immunopathogenesis of autoimmune disease. In: Luebke R, House R, Kimber I (eds) Immunotoxicology and immunopharmacology, 3rd edn. CRC Press, Boca Raton, pp 423–436
Fairweather D, Rose NR (2007b) Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41:118–122
Fairweather D, Yusung S, Frisancho-Kiss S, Barrett M, Gatewood S, Steele R, Rose NR (2003) IL-12Rβ1 and TLR4 increase IL-1β and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 170:4731–4737
Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Gatewood SJL, Davis SE, Njoku DB, Rose NR (2004a) IFN-γ protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines TGF-β1, IL-1β, and IL-4 in the heart. Am J Pathol 165:1883–1894
Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR (2004b) Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity 37:131–145
Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, Gatewood SJL, Rose NR (2005) IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-γ and macrophage and neutrophil populations in the heart. J Immunol 174:261–269
Fairweather D, Frisancho-Kiss S, Rose NR (2008) Sex differences in autoimmune disease from a pathologic perspective. Am J Pathol 173:600–609
Frisancho-Kiss S, Nyland JF, Davis SE, Frisancho JA, Barrett MA, Rose NR, Fairweather D (2006) Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rβ1 signaling and IFN-γ increase inflammation in males independent from STAT4. Brain Res 1126:139–147
Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Rose NR, Fairweather D (2007) Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 178:6710–6714
Frisancho-Kiss S, Coronado MJ, Frisancho JA, Lau VM, Rose NR, Klein SL, Fairweather D (2009) Gonadectomy of male BALB/c mice increases Tim-3+ alternatively activated M2 macrophages, Tim-3+ T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav Immunol 23:649–657
Gaciong Z, Symonides B (2010) Hypertension 2010: what was new for the cardiologist? Expert Opin Pharmacother 11:2579–2597
Glantz SA, Parmley WW (2001) Passive smoking causes heart disease. In: Acosta D Jr (ed) Cardiovascular toxicology, 3rd edn. Talyor and Francis, London, pp 402–424
Goodson NJ (2004) Cardiac involvement in rheumatoid arthritis. In: Doria A, Pauletto P (eds) The heart in systemic autoimmune diseases. Elsevier, Amsterdam, pp 121–143
Gottdiener JS, Gay JA, VanVoorhees L, DiBianco R, Fletcher RD (1983) Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. Am J Cardiol 52:1281–1285
Grzybowski J, Bilinska ZT, Ruzyllo W, Kupsc W, Michalak E, Szczesniewska D, Poplawska W, Rydlewska-Sadowska W (1996) Determinants of prognosis of nonischemic dilated cardiomopathy. J Card Fail 2:77–85
Gualtierotti R, Biggioggero M, Penatti AE, Meroni PL (2010) Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 10:3–7
Gupta S, Markham DW, Drazner MH, Mammen PPA (2008) Fulminant myocarditis. Nat Clin Pract 5:693–706
Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12:204–212
Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508–519
Haque S, Gordon C, Isenberg D, Rahman A, Lanyon P, Bell A, Emery P, McHugh N, The LS, Scott DG, Akil M, Naz S, Andrews J, Griffiths B, Harris H, Youssef H, McLaren J, Toescu V, Devakumar V, Teir J, Bruce IN (2010) Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study. J Rheumatol 37:322–329
Holmqvist ME, Wdren S, Jacobsson LT, Klareskog L, Nyberg F, Rantapaa-Dahlqvist S, Alfredsson L, Askling J (2009) No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts. Arthritis Rheum 60:2861–2869
Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, Nieto FJ, Tell GS (1998) Cigarette smoking and progression of atherosclerosis. The Atheroslcerosis Risk in Communities (ARIC) Study. J Am Med Assoc 279:19–124
Huber SA (1997) Autoimmunity in myocarditis: relevance of animal models. Clin Immunol Immunopathol 83:93–102
Huber SA, Pfaeffle B (1994) Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol 68:5126–5132
Hulsmans M, Holvoet P (2010) The vicious circle between oxidative stress and inflammation in atherosclerosis. J Cell Mol Med 14:70–78
Ippolito A, Petri M (2008) An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol 26(5 suppl 51):S72–S79
Jameson JN, Kasper D, Harrison TR, Braunwald E, Fauci AS, Hauser SL, Longo DL (2005) Harrison’s principles of internal medicine. McGraw-Hill, New York
Kallwellis-Opara A, Dorner A, Poller W-C, Noutsias M, Kuhl U, Schultheiss H-P, Pauschinger M (2007) Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol 96:469–480
Kania G, Blyszczuk P, Eriksson U (2009) Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med 19:247–252
Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, Lindinger A, Bohm M (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648
Kinnula VL (2005) Production and degradation of oxygen metabolites during inflammatory states in the human lung. Curr Drug Targets Inflamm Allergy 4:465–470
Klienfeldt T, Nienaber CA, Kische S, Akin I, Turan RG, Korber T, Schneider H, Ince H (2010) Cardiac manifestation of the hypereosinophilic syndrome: new insights. Clin Res Cardiol 99:419–427
Kodavanti UP, Moyer CF, Ledbetter AD, Schladweiler MC, Costa DL, Hauser R, Christiani DC, Nyska A (2003) Inhaled environmental combustion particles cause myocardial injury in the Wistar Kyoto rat. Toxicol Sci 71:237–245
Kojima J, Miyazaki S, Fujiwara H, Kumada T, Kawai C (1988) Recurrent left ventricular mural thrombi in a patient with acute myocarditis. Heart Vessels 4:120–122
Kuh JH, Seo Y (2005) Transatrial resection of a left ventricular thrombus after acute myocarditis. Heart Vessels 20:230–232
Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793–2798
Kumar V, Abbas AK, Fausto N (2005) Robbins and Cotran pathologic basis of disease, 7th edn. Elsevier Saunders, Philadelphia
Laffer CL, Elijovich F (2010) Inflammation and therapy for hypertension. Curr Hypertens Rep 12:233–242
Leuschner F, Katus HA, Kaya Z (2009) Autoimmune myocarditis: past, present and future. J Autoimmun 33:282–289
Libby P, Ridker PM, Hansson GK, for the Leducq Transatlantic Network on Atherothrombosis (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54:2129–2138
Libby P, Okamoto Y, Rocha VZ, Folco E (2010) Inflammation in atherosclerosis: transition from theory to practice. Circ J 74:213–220
Lippmann M (2009a) Ambient air particulate matter. In: Lippman M (ed) Environmental toxicants: human exposures and their health effects, 3rd edn. Wiley, Hoboken, pp 317–365
Lippmann M (2009b) Ozone. In: Lippman M (ed) Environmental toxicants: human exposures and their health effects, 3rd edn. Wiley, Hoboken, pp 869–936
Looi JL, Edwards C, Armstrong GP, Scott A, Patel H, Hart H, Christiansen JP (2010) Characteristics and prognostic importance of myocardial fibrosis in patients with dilated cardiomyopathy assessed by contrast-enhanced cardiac magnetic resonance imaging. Clin Med Insights Cardiol 4:129–134
Mauderly JL, Garshick E (2009) Diesel exhaust. In: Lippman M (ed) Environmental toxicants: human exposures and their health effects, 3rd edn. Wiley, Hoboken, pp 551–631
Mayes MD (1999) Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect 107(suppl 5):743–748
McNeill E, Channon KM, Greaves DR (2010) Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. Clin Sci 118:641–655
Miller YI, Choi SH, Fang L, Harkewicz R (2009) Toll-like receptor-4 and lipoprotein accumulation in macrophages. Trends Cardiovasc Med 19:227–232
Nilsson J, Fredrikson GN (2010) The B cell in atherosclerosis: teaming up with the bad guys? Clin Chem 56:1789–1791
Nishikubo K, Imanaka-Yoshida K, Tamaki S, Hiroe M, Yoshida T, Adachi Y, Yasutomi Y (2007) Th1-type immune responses by Toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis. J Autoimmun 29:146–153
Pamukcu B, Lip GY, Devitt A, Griffiths H, Shantsila E (2010) The role of monocytes in atherosclerotic artery disease. Ann Med 42:394–403
Panoulas VF, Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Milionis HJ, Douglas KM, Nightingale P, Kitas GD (2009) Associations of interleukin-6 (IL-6)-174 G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis 204:178–183
Parke DV, Sapota A (1996) Chemical toxicity and reactive oxygen species. Int J Occup Med Environ Health 9:331–340
Persson M, Berglund G, Nelson JJ, Hedblad B (2008) Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malmo, Sweden. Atherosclerosis 200:191–198
Petri M (2006) Systemic lupus erythematosus: 2006 update. J Clin Rheumatol 12:37–40
Piro M, Bona RD, Abbate A, Biasucci LM, Crea F (2010) Sex-related differences in myocardial remodeling. J Am Coll Cardiol 55:1057–1065
Puntmann VO, Taylor PC, Mayr M (2011) Coupling vascular and myocardial inflammatory injury into a common phenotype of cardiovascular dysfunction: systemic inflammation and aging—a mini-review. Gerontology 57:295–303
Rappaport SM, Smith MT (2010) Epidemiology. Environment and disease risks. Science 330:460–461
Regitz-Zagrosek V (2006) Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 5:425–438
Rezaizadeh H, Sanchez-Ross M, Kaluski E, Klapholz M, Haider B, Gerula C (2010) Acute eosinophilic myocarditis: diagnosis and treatment. Acute Card Care 12:31–36
Robinson T, Smith A, Channer KS (2011) Reversible heart failure: the role of inflammatory activation. Postgrad Med J 87:110–115
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Roger VL, Turner MB, on behalf of the American Heart Association Heart Disease and Stroke Statistics Writing Group (2011) Heart disease and stroke statistics- 2011 update: a report from the American Heart Association. Circulation 104:276–308
Rubin LJ, Parker JL, Adams HR (2001) Bacterial lipopolysaccharide (endotoxin) and myocardial dysfunction. In: Acosta D Jr (ed) Cardiovascular toxicology, 3rd edn. Taylor and Francis, New York, pp 222–268
Sakao S, Tanabe N, Tatsumi K (2010) The estrogen paradox in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 299:L435–L438
Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL (2000) Fine particulate air pollution and mortality in 20 US cities, 1987–1994. N Engl J Med 343:1742–1749
Samet JM, Neta GI, Wang SS (2009) Secondhand smoke. In: Lippman M (ed) Environmental toxicants: human exposures and their health effects, 3rd edn. Wiley, Hoboken, pp 703–755
Schultz JC, Hilliard AA, Cooper LT, Rihal CS (2009) Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 84:1001–1009
Shah RS, Cole JW (2010) Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther 8:917–932
Shaw LJ, Bugiardini R, Merz CNB (2009) Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 54:1561–1575
Sheu JJ, Chiou HY, Kang JH, Chen YH, Lin HC (2010) Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study. Stroke 41:244–249
Shi G-P (2010) Immunomodulation of vascular diseases: atherosclerosis and autoimmunity. Eur J Vasc Endovasc Surg 39:485–494
Shih H, Lee B, Lee RJ, Boyle AJ (2011) The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol 57:9–17
Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351:2611–2618
Sperelakis N, Sunagawa M, Nakamura M, Yokoshiki H, Seki T (2001) Toxins that affect ion channels, pumps and exchangers. In: Acosta D Jr (ed) Cardiovascular toxicology, 3rd edn. Taylor and Francis, New York, pp 328–373
Steiner G, Urowitz M (2009) Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum 38:372–381
Taleb S, Tedgui A, Mallat Z (2010) Adaptive T cell immune responses and atherogenesis. Curr Opin Pharmacol 10:197–202
Utell MJ, Samet JM (2009) Clinical perspective on respiratory toxicology. In: Lippmann M (ed) Environmental toxicants: human exposures and their health effects, 3rd edn. Wiley, Hoboken, pp 77–106
Van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lms WF, Visser M, Stehouwer CD, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Smulders YM, Dijkmans BA, Nurmohamed MT (2009) Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE investigation. Ann Rheum Dis 68:1395–1400
Vitale C, Mendelsohn ME, Rosano GMC (2009) Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 6:532–542
Wallberg-Jonsson S, Ohman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 24:445–451
Wang Y-X, da Cunha V, Vincelette J, White K, Velichko S, Xu Y, Gross C, Fitch RM, Halks-Miller M, Larsen BR, Yajima T, Knowlton KU, Vergona R, Sullivan ME, Croze E (2007) Antiviral and myocyte protective effects of murine interferon-β and -α2 in coxsackievirus B3-induced myocarditis and epicarditis in BALB/c mice. Am J Physiol Heart Circ Physiol 293:H69–H76
Wexler RK, Elton T, Pleister A, Feldman D (2009) Cardiomyopathy: an overview. Am Fam Physician 79:778–784
White HD, Chew DP (2008) Acute myocardial infarction. Lancet 372:570–584
Wong AH, Lau CS, Cheng PK, Ng AY, Lim WW (2011) Coxsackievirus B3-associated aseptic meningitis: an emerging infection in Hong Kong. J Med Virol 83:483–489
Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7:77–86
Yung CK, Helperin VL, Tomaselli GF, Winslow RL (2004) Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 83:281–297
Acknowledgments
This work was supported by National Institutes of Health Grant HL087033.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Fairweather, D. (2012). Atherosclerosis and Inflammatory Heart Disease. In: Dietert, R., Luebke, R. (eds) Immunotoxicity, Immune Dysfunction, and Chronic Disease. Molecular and Integrative Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-812-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-61779-812-2_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-811-5
Online ISBN: 978-1-61779-812-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)